News Newsletters BioCanRx Newsletters CSA Dispatch Media Releases Publications Events Video Archive NEWS & EVENTS > Media Releases 2023Dec 6, 2023 BioCanRx Welcomes Strategic Science Fund Investment2022Sep 23, 2022 Unique Hands-on Training Program in Biotherapeutics Manufacturing Expanding Across CanadaJun 17, 2022 First made-in-Canada CAR-T cell therapy for cancer shows promise in clinical trial2021Sep 13, 2021 Biomanufacturing partnership boosts Canada’s life-saving treatment and vaccine capacity2020Sep 22, 2020 BioCanRx Invests $10M in Promising New Cancer Immunotherapy Research and Biomanufacturing to Benefit CanadiansJul 8, 2020 Protecting cancer patients from COVID-19: world-first clinical trial tests a novel immune-boosting strategy2018Oct 17, 2018 Media Advisory – Immunotherapy: Game-changing research in Alberta Public Symposia hosted by BioCanRx and Alberta Cancer Foundation2017Nov 1, 2017 BioCanRx, Network of Networks and Ottawa Regional Cancer Foundation Release Webinar about Cancer Clinical TrialsOct 11, 2017 Ontario start-up makes major deal to develop cancer-fighting virusesFeb 15, 2017 BioCanRx, and partners, announce funding to manufacture first made-in-Canada CAR-T cells2016Mar 18, 2016 BioCanRx Board announces appointment of new CEO and PresidentFeb 17, 2016 Canada-wide call for research proposals to accelerate biotherapies for cancer patientsFeb 4, 2016 Together, we can! A message from Dr. John Bell on World Cancer DayJan 18, 2016 Health research champion Drew Lyall dies at 492015Sep 16, 2015 $16-million from supporters and partners fuels research to improve detection, treatment for high-risk, inherited cancersJul 10, 2015 Cancer patients treated in world-first clinical trial of Canadian viral therapyApr 20, 2015 Pancreatic cancer loses viral defences when talking with supporting cells2014Dec 15, 2014 The Ottawa Hospital to host $60M national research network for innovative cancer treatments Media Contact Vanessa Nelson Director, Communications 613-739-6203 vnelson@biocanrx.com
